RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Daniel A. Alicata to Psychiatric Status Rating Scales

This is a "connection" page, showing publications Daniel A. Alicata has written about Psychiatric Status Rating Scales.
  1. Cloak CC, Alicata D, Ernst TM, Chang L. Psychiatric Symptoms, Salivary Cortisol and Cytokine Levels in Young Marijuana Users. J Neuroimmune Pharmacol. 2015 Jun; 10(2):380-90.
    View in: PubMed
    Score: 0.029
  2. King G, Alicata D, Cloak C, Chang L. Psychiatric symptoms and HPA axis function in adolescent methamphetamine users. J Neuroimmune Pharmacol. 2010 Dec; 5(4):582-91.
    View in: PubMed
    Score: 0.021
  3. Ho BC, Alicata D, Mola C, Andreasen NC. Hippocampus volume and treatment delays in first-episode schizophrenia. Am J Psychiatry. 2005 Aug; 162(8):1527-9.
    View in: PubMed
    Score: 0.015
  4. Ho BC, Alicata D, Ward J, Moser DJ, O'Leary DS, Arndt S, Andreasen NC. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am J Psychiatry. 2003 Jan; 160(1):142-8.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support